COST-EFFECTIVENESS ANALYSIS OF AUGMENTIN 625 MG AND AUCLANITYL 500 MG/125 MG IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA. Vietnam Journal of Community Medicine, v. 67, n. CD15, 25 Sept.2026.